Stepwise Approach to Increasing Telmisartan/Amlodipine Dosage in Hypertension

Rationale for Stepwise Approach

• The American College of Cardiology suggests that an episode of giddiness in a hypertensive patient on telmisartan/amlodipine (40/5) indicates potential hypotension, making a gradual dose increase more appropriate to minimize adverse effects 1
• Normal blood glucose levels rule out hypoglycemia as a cause of giddiness, suggesting the symptom may be medication-related 1

Recommended Approach

• The American College of Cardiology recommends increasing telmisartan to 80 mg while maintaining amlodipine at 5 mg, as this reduces the risk of dose-related adverse effects like peripheral edema 1, 3
• The European Heart Journal suggests reassessing blood pressure control and tolerability after 4 weeks of treatment 2

Monitoring Parameters

• The American Heart Association recommends monitoring blood pressure measurements at each follow-up visit, as well as symptoms of hypotension (dizziness, lightheadedness, syncope) 4, 5
• The American Heart Association also suggests monitoring signs of peripheral edema, especially with amlodipine dose increases 3

Important Considerations

• The American College of Cardiology notes that the previous episode of giddiness raises concern for orthostatic hypotension, and considers administering the medication at bedtime if orthostatic symptoms occur during daytime 1